背景:在美国,与其他种族/种族群体相比,拉丁美洲人的宫颈癌发病率最高,部分原因是在筛查方面存在显著差异。妨碍获得和参与筛查的社会和结构条件包括语言障碍,关注文档状态,后勤问题(例如,交通运输,有限的门诊时间),以及关于谦虚和滥交的文化信仰。为了克服这些挑战,自我取样用于人乳头瘤病毒(HPV)DNA检测已成为在这一人群中促进宫颈癌筛查的潜在有前景的方法.因此,本系统综述旨在评估美国拉丁裔人群中HPV自我取样的可接受性.
方法:使用EBSCOhost和PubMed数据库,我们搜索了过去20年(2003-2023年)发表的研究,这些研究描述了拉丁美洲人参与HPV自我取样.11篇文章符合纳入标准。
结果:大多数研究是在佛罗里达州进行的,加州,波多黎各,是单臂设计,并涉及使用社区卫生工作者和西班牙语材料(例如,小册子)。在整个研究中,大多数参与者报告说,自采样在易用性方面是可以接受的,舒适(缺乏疼痛),隐私,和便利;然而,一些妇女担心自我取样的准确性,或者她们是否正确地进行了样本收集。
结论:考虑到高可接受性,在面临重大筛查障碍的人群中,自行采集宫颈阴道样本进行HPV检测可能为增强参与宫颈癌筛查提供可行的选择.
BACKGROUND: Latinas experience the greatest cervical cancer incidence compared with other ethnic/racial groups in the United States (US) due in part to significant disparities in screening uptake. Social and structural conditions that impede access to and participation in screening include language barriers, concerns about documentation status, logistical issues (e.g., transportation, limited clinic hours), and cultural beliefs regarding modesty and promiscuity. To overcome these challenges, self-sampling for human papillomavirus (HPV) DNA testing has emerged as a potentially promising method for promoting cervical cancer screening among this population. Thus, this systematic review aimed to assess the acceptability of HPV self-sampling among US Latinas.
METHODS: Using EBSCOhost and PubMed databases, we searched for studies published in the past two decades (2003-2023) that described participation in HPV self-sampling among Latinas. Eleven articles met inclusion criteria.
RESULTS: The majority of studies were conducted in Florida, California, and Puerto Rico, were single-arm designs, and involved the use of community health workers and Spanish-language materials (e.g., brochures). Across studies, the majority of participants reported that self-sampling was acceptable with respect to ease of use, comfort (lack of pain), privacy, and convenience; however, some women were concerned about the accuracy of self-sampling or whether they had performed sample collection correctly.
CONCLUSIONS: Given the high acceptability, self-collection of cervicovaginal samples for HPV testing may offer a feasible option for enhancing participation in cervical cancer screening in this population that encounters significant barriers to screening.